Expression of v-rel in a replication competent virus: transformation and biochemical characterization
- PMID: 1656369
Expression of v-rel in a replication competent virus: transformation and biochemical characterization
Abstract
The avian reticuloendotheliosis virus strain T (REV-T) transforms bone marrow cells and may cause phenotypic changes in fibroblasts. Both events are thought to result from expression of the v-rel oncoprotein, a member of the NF-kappa B family of transcription factors. Most REV stocks contain a cytopathic and immunosuppressive helper virus (REV-A) unrelated to standard avian retroviruses, and thus the degree to which v-rel expression alone contributes to the transformed phenotype in bone marrow cells and fibroblasts is complicated by helper virus expression. To gain a more accurate picture of how v-rel contributes to transformation, we have cloned the v-rel gene into a replication-competent avian retrovirus vector (RCAS) and have expressed it in both chick embryo fibroblasts (CEF) and bone marrow cells. Transfection of RCAS-rel into CEF readily produced a partially transformed phenotype, demonstrating that expression of the v-rel protein is sufficient for fibroblast transformation. The RCAS-rel virus also transformed bone marrow cells in vitro, but required culture conditions different from those normally required for transformation by REV-T. The v-rel protein expressed in transformed CEF was biochemically indistinguishable from that expressed in transformed bone marrow cells, being localized to the cytoplasm and the nucleus, and forming a complex with cellular proteins. We also demonstrate that the RCAS-rel-transformed hematopoietic cells exhibited a distinct differentiation phenotype.
Similar articles
-
The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.Oncogene. 1988 Oct;3(4):349-55. Oncogene. 1988. PMID: 2856247
-
Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts.Oncogene. 1992 Jun;7(6):1137-47. Oncogene. 1992. PMID: 1594245
-
Mutational analysis of v-rel, the oncogene of reticuloendotheliosis virus strain T.Oncogene. 1990 May;5(5):625-34. Oncogene. 1990. PMID: 2189101
-
Molecular mechanisms of transformation by the v-rel oncogene.Crit Rev Oncog. 1991;2(4):293-309. Crit Rev Oncog. 1991. PMID: 1958712 Review.
-
Transformation of avian lymphoid cells by reticuloendotheliosis virus.Mutat Res. 1988 Jan;195(1):79-90. doi: 10.1016/0165-1110(88)90016-4. Mutat Res. 1988. PMID: 2827014 Review.
Cited by
-
Avian I kappa B alpha is transcriptionally induced by c-Rel and v-Rel with different kinetics.J Virol. 1995 Sep;69(9):5383-90. doi: 10.1128/JVI.69.9.5383-5390.1995. J Virol. 1995. PMID: 7636983 Free PMC article.
-
Hormone-regulated v-rel estrogen receptor fusion protein: reversible induction of cell transformation and cellular gene expression.EMBO J. 1992 Dec;11(12):4641-52. doi: 10.1002/j.1460-2075.1992.tb05566.x. EMBO J. 1992. PMID: 1425595 Free PMC article.
-
Myb proteins inhibit fibroblast transformation by v-Rel.Mol Cancer. 2006 Nov 2;5:54. doi: 10.1186/1476-4598-5-54. Mol Cancer. 2006. PMID: 17081304 Free PMC article.
-
AP-1 factors play an important role in transformation induced by the v-rel oncogene.Mol Cell Biol. 1998 May;18(5):2997-3009. doi: 10.1128/MCB.18.5.2997. Mol Cell Biol. 1998. PMID: 9566919 Free PMC article.
-
The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.EMBO J. 1996 Jul 15;15(14):3640-50. EMBO J. 1996. PMID: 8670867 Free PMC article.